Feature | June 06, 2013

Radiation Dose Tracking and Reporting System Sees Expanding Adoption

Two more hospitals install GE Healthcare’s DoseWatch

June 6, 2013 — Many providers, and even consumers, are now aware of low-dose technologies, such as computed tomography (CT) systems that enable high-quality images with low radiation. Today, a growing number of hospitals are also adopting monitoring technology that takes dose management to the next level.

GE Healthcare offers DoseWatch, a radiation dose-tracking and reporting solution that can help facilities analyze patient exposure levels over time to ensure “as low as reasonably achievable radiation” use, or the ALARA principle.

Harnett Health in Dunn, N.C. and Nash General Hospital in Rocky Mount, N.C., recently announced adoption of DoseWatch. Harnett Health is a private, nonprofit system and includes Betsy Johnson Hospital, a 101-bed hospital, and Central Harnett Hospital, a new 50-bed facility with plans to expand in the future. Nash General Hospital is a 280-bed acute care facility.

Each site will use data captured by DoseWatch to identify outliers in radiation dose in imaging procedures in order to standardize and optimize protocols. Harnett Health and Nash join a growing numbers of hospitals adopting DoseWatch in the United States, and are helping to pioneer dose optimization and low-dose imaging.

DoseWatch enables healthcare providers to track and evaluate dose levels on radiation emitting diagnostic and screening procedures. Providers can generate statistical analyses based on device, operator or protocol. By identifying areas of variation, hospitals can change how dose is administered to maximize effective, and safe, diagnostic imaging.

GE experts will leverage data from DoseWatch for use in best practices training to help clinical staff at Harnett Health, Nash and other hospitals to further optimize dose organization-wide. DoseWatch supplements existing dose awareness technologies and can be used with equipment from various vendors.

DoseWatch is part of the GE Blueprint for low dose, a comprehensive program that helps healthcare providers integrate CT technologies, education and process improvements, and data analysis to reduce patient radiation dose from Computed Tomography (CT) by up to 50 percent. 

Harnett Health and Nash General join more than 100 installations of DoseWatch around the globe to date. 

For more information: www.gehealthcare.com/en

Related Content

Aidoc Earns FDA Approval for AI for C-spine Fractures
Technology | Artificial Intelligence | June 11, 2019
Radiology artificial intelligence (AI) provider Aidoc announced the U.S. Food and Drug Administration (FDA) has cleared...
SCCT Announces 2019 Gold Medal Award Recipients
News | Computed Tomography (CT) | June 05, 2019
The Society of Cardiovascular Computed Tomography (SCCT) will present the 2019 Gold Medal Award to Jonathon Leipsic, M....
Applications Open for ASRT Foundation and Canon Medical's Safety FiRsT Grant Program
News | Radiation Dose Management | May 31, 2019
The ASRT Foundation and Canon Medical Systems are now accepting applications for the 2019 Safety FiRsT grant program,...
Einstein Healthcare Network found that use of automated power injectors reduced CT contrast extravasation rates over a 30-month period.

Einstein Healthcare Network found that use of automated power injectors reduced CT contrast extravasation rates over a 30-month period.

Feature | Computed Tomography (CT) | May 30, 2019 | By Jeff Zagoudis
As of 2015, approximately 79 million computed tomography (CT) scans were performed each year in the U.S.
Sponsored Content | Webinar | Computed Tomography (CT) | May 30, 2019
This webinar will explain technical considerations when performing cardiac CT angiography in pediatric patients.
Sponsored Content | Webinar | Computed Tomography (CT) | May 30, 2019
Chest pain is one of the most frequent reasons for an evaluation in the emergency room.There are multiple imaging mod
Vast Majority of Heavy Smokers Not Screened for Lung Cancer
News | Lung Cancer | May 29, 2019
Out of more than 7 million current and former heavy smokers, only 1.9 percent were screened for lung cancer in 2016...
ControlRad Announces FDA Clearance and Launch of ControlRad Trace
Technology | Radiation Dose Management | May 23, 2019
ControlRad Inc. announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its ControlRad...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
MaxQ AI Launches Accipio Ax Slice-Level Intracranial Hemorrhage Detection
Technology | Computer-Aided Detection Software | May 21, 2019
Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that Accipio Ax will begin shipping in August...